Trade Summary

4 days ago, Schmid Timothy, serving as EVP, WW Chair, MedTech at Johnson & Johnson (JNJ), sold 22,623 shares at $244.33 per share, for a total transaction value of $5,527,506.00. Following this transaction, Schmid Timothy now holds 27,560 shares of JNJ.

This sale represents a 45.00% decrease in Schmid Timothy's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 18, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, meaning the disclosure happened on the same day as the trade.

Johnson & Johnson operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - GENERAL industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.